JULIAN MAGADAN MD NPI 1568660389

NPI Information

  • NPI: 1568660389
  • Provider Name: JULIAN MAGADAN, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4330 WORNALL RD STE 40
    KANSAS CITY, MO
    ZIP 64111
  • Phone: (816) 531-0930

Map and Directions

Get Directions

NPI Details

Julian Magadan, MD is a rheumatology internal medicine in Kansas City, MO with 18 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Julian Magadan, MD NPI is 1568660389. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:2007

The provider's business location address is:

4330 WORNALL RD STE 40
KANSAS CITY, MO
ZIP 64111-940
Phone: (816) 531-0930
Fax: (816) 531-2807

The NPI 1568660389 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Uric acid level, blood (HCPCS:84550)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Rheumatoid factor level (HCPCS:86431)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Urinalysis, manual test (HCPCS:81002)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • Vitamin d-3 level (HCPCS:82306)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Measurement of hepatitis a antibody (HCPCS:86708)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Liver function blood test panel (HCPCS:80076)
  • Blood creatinine level (HCPCS:82565)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Transferrin (iron binding protein) level (HCPCS:84466)

The enumeration date for this NPI number is 7/3/2007 and was last updated on 3/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine9406874KANSASNo
2207RR0500XInternal MedicineRheumatology04-35874KANSASYes
3207RR0500XInternal MedicineRheumatology2015039924MISSOURINo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.